Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) EPS (Basic): 2018-2024

Historic EPS (Basic) for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to -$0.02.

  • Pharming Group N.V's EPS (Basic) rose 6730.52% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.15, marking a year-over-year increase of 422.78%. This contributed to the annual value of -$0.02 for FY2024, which is 12.50% down from last year.
  • Pharming Group N.V's EPS (Basic) amounted to -$0.02 in FY2024, which was down 12.50% from -$0.02 recorded in FY2023.
  • Over the past 5 years, Pharming Group N.V's EPS (Basic) peaked at $0.06 during FY2020, and registered a low of -$0.02 during FY2024.
  • Its 3-year average for EPS (Basic) is -$0.00, with a median of -$0.02 in 2023.
  • Data for Pharming Group N.V's EPS (Basic) shows a maximum YoY slumped of 176.19% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Pharming Group N.V's EPS (Basic) stood at $0.06 in 2020, then crashed by 56.90% to $0.03 in 2021, then declined by 16.00% to $0.02 in 2022, then tumbled by 176.19% to -$0.02 in 2023, then declined by 12.50% to -$0.02 in 2024.